Veru to present at the h.c. wainwright bioconnect 2021 conference on january 11th, 2021

Miami, jan. 04, 2021 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, today announced that the company will present at the h.c. wainwright bioconnect 2021 conference. the presentation will be available on-demand through the conference from january 11-14, 2021 starting at 6:00 a.m. et.
VERU Ratings Summary
VERU Quant Ranking